The Frequency of Ras Mutations in Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ras proteins are frequently mutated in various cancers.
• Existing literature shows significant variability (10%-30%) in reported Ras mutation frequencies.
• This inconsistency stems from data aggregation biases and the influence of specific cancer types and Ras isoforms.

Purpose of the Study:

• To establish a definitive Ras mutation frequency across all major cancer types and isoforms.
• To estimate the global annual incidence of Ras-mutant cancers.
• To identify Ras isoform and mutation-specific trends relevant for targeted therapies.

Main Methods:

• Cross-referencing data from all major publicly accessible cancer mutation databases.
• Calculating reliable mutation frequency values for each Ras isoform in all major cancer types.
• Applying these frequencies to U.S. cancer incidence statistics for global estimations.

Main Results:

• Approximately 19% of all cancer patients harbor Ras mutations.
• This equates to an estimated 3.4 million new Ras-mutant cancer cases worldwide annually.
• Significant trends in Ras isoform and mutation prevalence across different cancer types were identified.

Conclusions:

• Ras mutations are present in approximately 19% of cancer patients globally.
• The findings provide a more accurate estimate of Ras mutation burden in cancer.
• Understanding these mutation patterns is crucial for developing and refining Ras-targeted cancer therapies.